Understand the Place in Therapy of Delafloxacin

May 2026

Delafloxacin (Baxdela) is a new oral and IV “quinolone” antibiotic.

It will be a twice-daily option for treating bacterial skin infections or community-acquired bacterial pneumonia (CABP) in adults.

But don’t expect delafloxacin to fly off your shelves.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Contraceptives Be Ready to Dispense Ringza, a New Contraceptive Vaginal Ring
Infectious Diseases Understand the Place in Therapy of Delafloxacin
Pediatrics Help Optimize Care for Children With Dyslipidemia
Women's Health Estrogen Patch Shortages: How to Help
Rumor vs Truth Listen for Patient Questions About Gabapentin
Pain Brush Up on Non-Opioid Pain Medications
Seizures Improve Safety With Antiseizure Meds
NatMed Spotlight Sort Out Claims About Lion’s Mane Mushroom